SomnoMed (ASX:SOM) Long-Term Debt : A$15.69 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed Long-Term Debt?

SomnoMed's Long-Term Debt for the quarter that ended in Dec. 2023 was A$15.69 Mil.

SomnoMed's quarterly Long-Term Debt declined from Dec. 2022 (A$20.68 Mil) to Jun. 2023 (A$16.36 Mil) and declined from Jun. 2023 (A$16.36 Mil) to Dec. 2023 (A$15.69 Mil).

SomnoMed's annual Long-Term Debt declined from Jun. 2021 (A$2.35 Mil) to Jun. 2022 (A$2.01 Mil) but then increased from Jun. 2022 (A$2.01 Mil) to Jun. 2023 (A$16.36 Mil).

SomnoMed Long-Term Debt Historical Data

The historical data trend for SomnoMed's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Long-Term Debt Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Debt

Get a 7-Day Free Trial

2.51

2.35

2.01

16.36

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															6.09	2.01	20.68	16.36	15.69

SomnoMed (ASX:SOM) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

SomnoMed Long-Term Debt Related Terms

Thank you for viewing the detailed overview of SomnoMed's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (ASX:SOM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines